Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary radiotherapy for subglottic carcinoma

B J Haylock1, G P Deutsch

  • 1Sussex Radiotherapy and Oncology Centre, Royal Sussex County Hospital, Brighton, East Sussex, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Royal College of Radiologists' fractionation survey. 1989.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014
Same author

Permanent corneal limbal stem cell dysfunction following radiotherapy for orbital lymphoma.

Eye (London, England)·2001
Same author

Penile cancer: a case for guidelines.

Annals of the Royal College of Surgeons of England·2001
Same author

Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy.

International journal of radiation oncology, biology, physics·2000
Same author

The use of neoadjuvant CMF to avoid mastectomy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·1999
Same author

Stage I endometrial carcinoma: the role of neoadjuvant progesterone therapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·1993

Primary radiotherapy to the neck alone for laryngeal subglottic carcinoma yielded favorable survival rates, challenging the necessity of mediastinal radiotherapy. This approach showed promising results in a retrospective patient review.

Area of Science:

  • Otolaryngology
  • Radiation Oncology
  • Oncology

Background:

  • Subglottic carcinoma of the larynx is a rare malignancy.
  • Treatment traditionally involves radiotherapy, often including the mediastinum.
  • The optimal radiotherapy strategy requires further investigation.

Purpose of the Study:

  • To evaluate the outcomes of primary radiotherapy to the neck alone for laryngeal subglottic carcinoma.
  • To assess survival rates and patterns of failure in patients treated with this approach.
  • To compare these results with expectations and investigate surgeon perceptions of radiotherapy.

Main Methods:

  • Retrospective review of 23 patients treated between 1976 and 1990 with primary neck radiotherapy.
  • Radiotherapy technique involved small parallel opposed wedged fields to the neck; no mediastinal radiotherapy was used.

Related Experiment Videos

  • Actuarial survival analysis and a national survey of otolaryngologists regarding treatment perceptions.

    • Main Results:

    • A 2-year overall survival of 69.0% (78.3% excluding intercurrent deaths) was observed.
    • Two-year disease-free survival was 68.6%, with salvage surgery for recurrences in two T3 cases.
    • No clinical mediastinal relapse occurred; a surgeon survey indicated pessimistic perceptions of radiotherapy efficacy.

    Conclusions:

    • Primary radiotherapy to the neck alone can achieve better-than-expected results for laryngeal subglottic carcinoma.
    • Conventional mediastinal radiotherapy may not be necessary, potentially reducing treatment toxicity.
    • Surgeons may hold an overly pessimistic view of radiotherapy's role in managing this condition.